MET copy number | |||||
---|---|---|---|---|---|
Case no. (%) | >3 copies (%) | P | Loss (%) | P | |
Gender | |||||
Male | 12 (43) | 2 (40) | 0.89 | 3 (38) | 0.72 |
Female | 16 (57) | 3 (60) | 5 (62) | ||
Age (years) | |||||
≥60 | 8 (29) | 1 (20) | 0.65 | 2 (25) | 0.8 |
<60 | 20 (71) | 4 (80) | 6 (75) | ||
B symptom | |||||
Present | 6 (22) | 1 (20) | 0.9 | 0 (0) | 0.08 |
Absent | 21 (78) | 4 (80) | 8 (100) | ||
Perforation | |||||
Present | 6 (21) | 3 (60) | 0.02 | 1 (13) | 0.48 |
Absent | 22 (79) | 2 (40) | 7 (87) | ||
Ann Arbor stage | |||||
I or II | 23 (85) | 5 (100) | 0.31 | 7 (87) | 0.83 |
III or IV | 4 (15) | 0 (0) | 1 (13) | ||
Immunophenotype | |||||
GCB | 7 (25) | 1 (20) | 0.78 | 3 (38) | 0.34 |
Non-GCB | 21 (75) | 4 (80) | 5 (62) |